World Duchenne Awareness Day webinar was held at JAICARE Hospital, Madurai
6/10/2024
Clinical study results of Neu REFIX B-glucans & research updates by Dr. K. Raghavan 06 Oct 2024 Dr. Raghav
About
GN Corporation
Company Policy
Based on Japan’s excellent medical technology, GN Corporation will disseminate new solutions to the world that span the fields of cell culture, tissue engineering, regenerative medicine, medical devices, medical devices, metadata, databases, artificial intelligence, preventive medicine, and health foods.
We will hold academic exchange meetings to promote exchange between different fields such as clinical medicine, materials, and science, and contribute to the development of regenerative medicine.
Partner companies and facilities
| Japan-In dia BioSciences (P) Ltd | B6, 13, Zakariah Colony III St, Choolaimedu Chennai 600 094, TN, INDIA Tel: +91-44 -23720805, 23720806, 94440-82048 Fax: +91-44 – 24732186 |
|---|---|
| Nichi-in Center for Regenerative Medic ine, Japan-India Regenerative Medicine | III F, LICET, Loyola Campus, Nungambakkam, Chennai 600094, TN, India Tel: +91-44-28174743, +91-44-64549484 Fax: +91-44-24732186 |
Profile
| Company name | GN Corporation Co Ltd |
|---|---|
| Location | 〒400-0866 3-8 Wakamatsu, Kofu Yamanashi, JAPAN TEL. 055-235-7527 FAX. 055-235-7569 Email: info@gncorporation.com |
| Established. | August 2002 |
| Bank | Yamanashi Central Bank, Rakuten Bank |
Research and Patents
| Patent No. 5863089 | Gel film for the treatment of corneal endothelitis cell defects |
|---|---|
| Patent No. 6373241 | How cells are stored |
| Patent No. 6714247 | Urethral stenosis treatment agent and urethral stenosis treatment method |
| Patent No. 6757578 | Method for enhancing the function of immune and blood cells by TGP-containing storage solution and microgravity load |
Invest Japan
latest news
GN Corporation hosted a Morning seminar on Neu REFIX at the AOMC-JMS 2024 conference at Nara, Japan
6/10/2024
Neu REFIX pre-clinical studies in mdx mice @ AOMC-JMS 2024 05 Oct 2024 Disease modifying approach in managing
Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.
17/8/2024
At International Conference in Yokohama, Japan 17 Aug 2024 Nichi BRITE Beta glucan administration resulted in
